Inhaler
Latest AstraZeneca AB Patents:
- Method for the manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and polymorphic forms thereof
- Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases
- Dendrimer formulations
- GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof
- PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS
Description
FIG. 1 is a perspective view of the inhaler;
FIG. 2 is a bottom elevation of the inhaler;
FIG. 3 is a rear elevation of the inhaler;
FIG. 4 is a top elevation of the inhaler;
FIG. 5 is a side elevation of the inhaler; and,
FIG. 6 is a front elevation of the inhaler.
Claims
The ornamental design for an inhaler, as shown and described.
Referenced Cited
Patent History
Patent number: D449882
Type: Grant
Filed: Sep 25, 2000
Date of Patent: Oct 30, 2001
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Søren Christrup (Struer), Anders Geert-Jensen (Höjberg), Mikal Jørgensen (Århus), Jørgen Rasmussen (Struer), Hugo Dines Schmidt (Århus)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Nixon & Vanderhye
Application Number: 29/129,874
Type: Grant
Filed: Sep 25, 2000
Date of Patent: Oct 30, 2001
Assignee: AstraZeneca AB (Sodertalje)
Inventors: Søren Christrup (Struer), Anders Geert-Jensen (Höjberg), Mikal Jørgensen (Århus), Jørgen Rasmussen (Struer), Hugo Dines Schmidt (Århus)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Nixon & Vanderhye
Application Number: 29/129,874
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)
International Classification: 2902;
International Classification: 2902;